Sidoti Lowers Earnings Estimates for USANA Health Sciences

Key Points

• Sidoti cut its FY2027 EPS forecast for USANA to $1.25 from $1.59. The article also cites a current-year consensus EPS estimate of $0.55.
• USANA missed quarterly expectations, reporting a loss of $0.11 per share versus analysts’ forecast of $0.11 profit, while revenue of $205.89 million fell short of the $217.42 million estimate.
• Analyst sentiment is negative: MarketBeat reports a consensus “Sell” rating, with two analysts rating the stock Sell and recent downgrades from Zacks Research and Wall Street Zen.

USANA Health Sciences, Inc. (NYSE:USNA - Free Report) - Analysts at Sidoti reduced their FY2027 earnings per share estimates for USANA Health Sciences in a research report issued to clients and investors on Thursday, November 5th. Sidoti analyst A. Lebiedzinski now forecasts that the company will post earnings of $1.25 per share for the year, down from their prior estimate of $1.59. The consensus estimate for USANA Health Sciences' current full-year earnings is $0.55 per share.

A number of other research firms also recently commented on USNA. Weiss Ratings reaffirmed a "sell (d)" rating on shares of USANA Health Sciences in a report on Monday, September 21st. Zacks Research downgraded USANA Health Sciences from a "hold" rating to a "strong sell" rating in a report on Wednesday, November 4th. Finally, Wall Street Zen lowered USANA Health Sciences from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. Two equities research analysts have rated the stock with a Sell rating. According to data from MarketBeat, USANA Health Sciences presently has a consensus rating of "Sell".

USANA Health Sciences Price Performance

Shares of USANA Health Sciences stock opened at $13.86 on Tuesday. USANA Health Sciences has a 52-week low of $12.57 and a 52-week high of $23.59. The firm has a market capitalization of $256.13 million, a PE ratio of -12.05, a price-to-earnings-growth ratio of 2.17 and a beta of 0.66. The company's fifty day moving average price is $14.60 and its two-hundred day moving average price is $17.91.

USANA Health Sciences (NYSE:USNA - Get Free Report) last issued its earnings results on Tuesday, November 3rd. The company reported ($0.11) EPS for the quarter, missing analysts' consensus estimates of $0.11 by ($0.22). The firm had revenue of $205.89 million during the quarter, compared to analyst estimates of $217.42 million. USANA Health Sciences had a negative net margin of 2.34% and a positive return on equity of 3.56%.

Institutional Trading of USANA Health Sciences

Several hedge funds have recently modified their holdings of USNA. Versant Capital Management Inc boosted its holdings in shares of USANA Health Sciences by 1,472.3% in the 2nd quarter. Versant Capital Management Inc now owns 1,588 shares of the company's stock worth $34,000 after acquiring an additional 1,487 shares in the last quarter. GAMMA Investing LLC grew its position in USANA Health Sciences by 689.4% during the 3rd quarter. GAMMA Investing LLC now owns 2,763 shares of the company's stock worth $40,000 after acquiring an additional 2,413 shares during the last quarter. State of Wyoming acquired a new stake in USANA Health Sciences during the 1st quarter valued at $57,000. GSA Capital Partners LLP acquired a new stake in USANA Health Sciences during the 2nd quarter valued at $250,000. Finally, State of Alaska Department of Revenue increased its holdings in USANA Health Sciences by 79.3% during the 3rd quarter. State of Alaska Department of Revenue now owns 11,950 shares of the company's stock valued at $172,000 after purchasing an additional 5,284 shares in the last quarter. Institutional investors and hedge funds own 54.25% of the company's stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops and sells nutritional supplements, healthy foods and personal-care products through a direct-selling business model. Its product portfolio includes vitamins and mineral supplements, meal-replacement and snack products, sports nutrition offerings, and skincare products marketed under the USANA and related brands.

Founded in 1992 by microbiologist and immunologist Myron W. Wentz, the company is headquartered in Salt Lake City, Utah. USANA distributes its products through a network of independent associates and preferred customers rather than primarily through traditional retail channels.

The company serves customers in markets across the Americas, Asia-Pacific and Europe, with a significant presence in countries including the United States, Canada, Australia, New Zealand, China, Hong Kong, Japan, South Korea, the Philippines, Singapore, Malaysia and Thailand.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.